Sara Crowder, MD
Gynecologic Oncology · Columbia, MONPI 1285689687
Payments from drug & device makers
What this record shows
This record is dominated by education: $58,250 of the $69,057 with a category attached, or 84.4%. Intuitive Surgical accounts for 99.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $31,228 and has fallen 89.0% since, to $3,431 in 2025. Among gynecologic oncology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $986.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$69K
- Myriad Genetic Laboratories, Inc.$70
- Organon$65
- Coopersurgical, Inc.$27
- Eisai Inc.$24
- Hologic Sales And Service, LLC$16
- plus $28 from 2 others
What the payments were for
- Speaking & faculty fees$4,5007%
- Travel & lodging$2,4934%
- Food & beverage$3,7895%
- Education$58,25084%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 62 | $68,826 |
| Myriad Genetic Laboratories, Inc. | 1 | $70 |
| Organon | 1 | $65 |
| Coopersurgical, Inc. | 2 | $27 |
| Eisai Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Gilead | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$67,986
- DA VINCI SP$500
How this compares
$69,057 in reported general payments places this provider in the 90th percentile of 38 gynecologic oncology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $464 |
| Ondansetron OdtOndansetron | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Columbia
- Mark HunterColumbia$6K
- Arwa MohammadColumbia$2K
- Erin TullerColumbia$614
- Kristopher LybargerKansas City$743K
- Premal ThakerSaint Louis$287K
- Matthew PowellSaint Louis$162K
- David MutchSaint Louis$26K
- Dan-Arin SilasiSaint Louis$23K
- Dineo KhabeleSaint Louis$22K
- Carolyn McCourtSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.